These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20590598)

  • 1. Being mindful of seven-transmembrane receptor 'guests' when assessing agonist selectivity.
    Kenakin T
    Br J Pharmacol; 2010 Jul; 160(5):1045-7. PubMed ID: 20590598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.
    Stott LA; Hall DA; Holliday ND
    Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses.
    Burgueño J; Pujol M; Monroy X; Roche D; Varela MJ; Merlos M; Giraldo J
    Sci Rep; 2017 Nov; 7(1):15389. PubMed ID: 29133887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for inverse agonism with constitutive receptor systems.
    Kenakin T
    Curr Protoc Pharmacol; 2006 Apr; Chapter 9():Unit9.5. PubMed ID: 22294179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Biased Agonism.
    Ehlert FJ
    Prog Mol Biol Transl Sci; 2018; 160():63-104. PubMed ID: 30470293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of adenosine A1 receptor agonist and antagonist pharmacology using Saccharomyces cerevisiae: implications for ligand screening and functional selectivity.
    Stewart GD; Valant C; Dowell SJ; Mijaljica D; Devenish RJ; Scammells PJ; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2009 Oct; 331(1):277-86. PubMed ID: 19641164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors.
    Strange PG
    Br J Pharmacol; 2008 Apr; 153(7):1353-63. PubMed ID: 18223670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineating biased ligand efficacy at 7TM receptors from an experimental perspective.
    Galandrin S; Onfroy L; Poirot MC; Sénard JM; Galés C
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt B):251-63. PubMed ID: 27107932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of assay formats on the estimation of melanocortin agonist affinity and efficacy using the operation model of agonism.
    Simon S; Young TJ; Nickolls SA
    Eur J Pharmacol; 2009 Aug; 615(1-3):33-9. PubMed ID: 19446549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of the receptor-state affinity constants of ligands in functional studies using wild type and constitutively active mutant receptors: Implications for estimation of agonist bias.
    Ehlert FJ; Stein RS
    J Pharmacol Toxicol Methods; 2017; 83():94-106. PubMed ID: 27725245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitating Ligand Bias Using the Competitive Model of Ligand Activity.
    Stahl EL; Ehlert FJ; Bohn LM
    Methods Mol Biol; 2019; 1957():235-247. PubMed ID: 30919358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The operational model of allosteric modulation of pharmacological agonism.
    Jakubík J; Randáková A; Chetverikov N; El-Fakahany EE; Doležal V
    Sci Rep; 2020 Sep; 10(1):14421. PubMed ID: 32879329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional selectivity and biased receptor signaling.
    Kenakin T
    J Pharmacol Exp Ther; 2011 Feb; 336(2):296-302. PubMed ID: 21030484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of functional assays for characterization of agonist ligands at G protein-coupled receptors.
    Niedernberg A; Tunaru S; Blaukat A; Harris B; Kostenis E
    J Biomol Screen; 2003 Oct; 8(5):500-10. PubMed ID: 14567777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional selectivity in GPCR modulator screening.
    Kenakin T
    Comb Chem High Throughput Screen; 2008 Jun; 11(5):337-43. PubMed ID: 18537555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity.
    Berg KA; Clarke WP
    Int J Neuropsychopharmacol; 2018 Oct; 21(10):962-977. PubMed ID: 30085126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superagonism at G protein-coupled receptors and beyond.
    Schrage R; De Min A; Hochheiser K; Kostenis E; Mohr K
    Br J Pharmacol; 2016 Oct; 173(20):3018-27. PubMed ID: 26276510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-directed trafficking of receptor stimulus.
    Chilmonczyk Z; Bojarski AJ; Sylte I
    Pharmacol Rep; 2014 Dec; 66(6):1011-21. PubMed ID: 25443729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Operational Models of Agonism and Allosterism at Receptors with Multiple Orthosteric Binding Sites.
    Gregory KJ; Giraldo J; Diao J; Christopoulos A; Leach K
    Mol Pharmacol; 2020 Jan; 97(1):35-45. PubMed ID: 31704718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple method for quantifying functional selectivity and agonist bias.
    Kenakin T; Watson C; Muniz-Medina V; Christopoulos A; Novick S
    ACS Chem Neurosci; 2012 Mar; 3(3):193-203. PubMed ID: 22860188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.